Preparation method of chitosan oligosaccharide -based polyelectrolyte styptic powder
A polyelectrolyte and chitosan oligosaccharide technology, applied in bandages, absorbent pads, medical science, etc., can solve the problem of hemostatic drugs that cannot meet the requirements, achieve good biocompatibility and biodegradability, small particles, and fast absorption Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
preparation example Construction
[0027]In a specific embodiment, the preparation method of the chitosan oligosaccharide-based polyelectrolyte hemostatic powder of the present invention first dissolves chitosan oligosaccharide and biocompatible anionic polyelectrolyte or amphoteric polyelectrolyte in deionized water. By reducing the pH value of the solution, the amino groups of chitosan molecules are protonated and positively charged, and interact with anionic polyelectrolytes or amphoteric polyelectrolytes to form complexes through Coulomb force. The polyelectrolyte complex is dried and pulverized to obtain chitosan polyelectrolyte hemostatic powder. The specific steps are:
[0028] 1) Prepare an aqueous solution of polyelectrolyte mixture containing chitosan oligosaccharide and anionic polyelectrolyte or amphoteric polyelectrolyte. Anionic polyelectrolytes or amphoteric polyelectrolytes are biocompatible polyelectrolytes containing -COO - 、-SO 3- 、-O-CS 2- ,-O-PO 3 2- Natural, semi-synthetic or synthet...
Embodiment 1
[0033] 10 grams of chitosan oligosaccharide, 13 grams of sodium polyacrylate and 1 g of gluconolactone were dissolved in 1 liter of deionized water, and incubated at 50° C. for 10 hours. After the polyelectrolyte complex was dried in a blast dryer at 50° C. for 60 hours, it was ball-milled for 1 hour with a ball mill to obtain chitosan polyelectrolyte hemostatic powder. The hemostatic powder has good biocompatibility and antibacterial property, and exhibits excellent hemostatic function. The measurement of coagulation index in vitro in this embodiment shows that the coagulation index in vitro is <41%; the hemostatic effect test result of the rabbit ear artery bleeding model shows that the hemostatic time is <97 seconds.
Embodiment 2
[0035] 10 grams of chitosan oligosaccharides, 10 grams of hyaluronic acid and 1 g of gluconolactone were dissolved in 1 liter of deionized water and kept at 50° C. for 10 hours. After the polyelectrolyte complex was dried in a blast dryer at 50° C. for 60 hours, it was ball-milled for 1 hour with a ball mill to obtain chitosan polyelectrolyte hemostatic powder. The hemostatic powder has good biocompatibility and antibacterial property, and exhibits excellent hemostatic function. The in vitro coagulation index measurement in this example shows that the in vitro coagulation index is <56%; the hemostatic effect test result of the rabbit ear artery bleeding model shows that the hemostatic time is <140 seconds.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap